Prognosis and follow-up of 135 patients with ischemic colitis over a five-year period

Table 1 Clinical features and clinical pattern of the ischemic colitis n (%)

Symptoms	No recurrence1 (n = 110)	Recurrence2 (n = 13)	P value
Acute abdominal pain	76 (69)	12 (92)	< 0.05
Haematochezia	90 (82)	11 (85)	0.4
Diarrhoea	41 (37)	6 (46)	0.2
AUBD sequence	57 (52)	7 (54)	0.4
Vomiting	20 (18)	5 (38)	< 0.05

¹Fulminant colitis 4, gangrenous colitis 8 and non-gangrenous colitis 98 (transient colitis 22, reversible colitis 42 and chronic segmental colitis 34);

²Transient colitis 5, reversible colitis 4 and 4 chronic segmental colitis. AUBD: Sequence of abdominal pain, urgent desire to defecate, and bloody diarrhoea.

Table 2 Univariate analysis of variables in patients with ischemic colitis without recurrence versus patients with recurrence n (%)

	No recurrence (n = 110)	Recurrence(n = 13)	P value
Men/women	56/54	6/7	0.8
Age ≥ 65 yr	91 (83)	12 (92)	0.7
Age ≥ 80 yr	32 (29)	4 (31)	1
Hypertension	66 (60)	10 (77)	0.4
Patients under NSAID treatments	32 (29)	5 (38)	0.5
≥ 3 comorbidities diseases1	43 (39)	4 (31)	0.8
Location
Pancolitis	4 (3)	0 (0)	1
≥ 2 locations	45 (41)	5 (38)	1
Caecum	6 (5)	1 (8)	0.5
Ascending colon	7 (6)	1 (8)	0.6
Hepatic flexure	8 (7)	1 (8)	1
Transverse colon	8 (7)	1 (8)	1
Splenic colon	23 (21)	3 (23)	1
Descending colon	45 (41)	2 (15)	0.08
Sigmoid colon	74 (67)	11 (85)	0.0001
Rectum	17 (15)	1 (8)	0.7
Clinical presentations
Non-gangrenous	98 (89)	13 (100)	0.8
Gangrenous	8 (7)	0 (0)	0.6
Fulminant	4 (3)	0 (0)	1

¹Comorbidities (diabetes, 44 patients; dyslipidaemia, 36; ischaemic heart disease, 34; cerebrovascular disease, 29; atrial fibrillation, 28; peripheral vascular disease, 24; congestive heart failure, 11; recent arterial hypertension, 11; malignancy, 3 and miscellaneous, 15). NSAID: Nonsteroidal anti-inflammatory drug.